Image

Accelerating the translation of ideas into products & services for the benefit of North Carolina, UNC-Chapel Hill and Beyond

Innovate Carolina’s Office of Technology Commercialization (OTC) helps translate the University of North Carolina at Chapel Hill’s inventions and findings into the commercial marketplace. It offers vital expertise to Carolina faculty and students who are engaged in a large and growing portfolio of sponsored and federally funded research, which often involves innovations with commercial potential. OTC works with Carolina’s researchers and inventors, as well as external research sponsors, collaborators, companies and investors.

As part of Innovate Carolina, OTC can help you: translate ideas into products and services that strengthen the economy and return revenue to the University, assess your technology’s commercial potential with patent landscaping and market research, launch a startup company through consulting, coaching, funding, mentorship and space, secure proof-of-concept grants for technology development, navigate technology patent applications and licensing agreements and structure partnerships that bring University research to market.

The UNC Patent and Invention Policy was established to ensure that inventions and discoveries in which the University has an interest will be utilized in a manner consistent with the public good through patent protection or other mechanisms as appropriate. This policy was recently revised to meet current policy guidelines and updated to clarify procedures and definitions. If you have questions about a patent or invention, reach out to the Office of Technology Commercialization for assistance.

Quick Links

Image
Image
Image
Available Technologies

Latest Stories

Jessica Hartman, Ph.D., conducting an experiment on CellRaft AIR System.

Single-cell solution

Cell Microsystems, a company with UNC-Chapel Hill origins, is leapfrogging traditional technologies for single-cell cloning, culturing, analysis and isolation. How does the firm help scientists in pharma-biotech organizations speed therapeutic breakthroughs by culturing 10 times more cells in one-tenth of the time?